These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23025453)

  • 21. Lung deposition of radiolabeled tiotropium in healthy subjects and patients with chronic obstructive pulmonary disease.
    Brand P; Meyer T; Weuthen T; Timmer W; Berkel E; Wallenstein G; Scheuch G
    J Clin Pharmacol; 2007 Oct; 47(10):1335-41. PubMed ID: 17625157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Not Available].
    Kasak V
    Vnitr Lek; 2013 Dec; 59(12):1041-2. PubMed ID: 24466606
    [No Abstract]   [Full Text] [Related]  

  • 23. Double-edged sword?
    Woodruff PG
    JAMA Intern Med; 2013 Jul; 173(13):1184-5. PubMed ID: 23689337
    [No Abstract]   [Full Text] [Related]  

  • 24. Triple inhalers for obstructive airways disease: will they be useful?
    Barnes PJ
    Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649
    [No Abstract]   [Full Text] [Related]  

  • 25. Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.
    Brusasco V; Hodder R; Miravitlles M; Korducki L; Towse L; Kesten S
    Thorax; 2006 Jan; 61(1):91. PubMed ID: 16396956
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tiotropium: new about known].
    Stepanian IE
    Ter Arkh; 2008; 80(3):82-4. PubMed ID: 18441692
    [No Abstract]   [Full Text] [Related]  

  • 27. A step forward in COPD management: reading between the lines.
    Chapman KR
    Chest; 2012 Nov; 142(5):1082-1085. PubMed ID: 23131928
    [No Abstract]   [Full Text] [Related]  

  • 28. [Safety of tiotropium therapy in chronic obstructive lung diseases (COPD)].
    Osztovits J; Fehér J
    Orv Hetil; 2010 May; 151(18):749-50. PubMed ID: 20410002
    [No Abstract]   [Full Text] [Related]  

  • 29. Stepping down therapy in COPD.
    Reilly JJ
    N Engl J Med; 2014 Oct; 371(14):1340-1. PubMed ID: 25196116
    [No Abstract]   [Full Text] [Related]  

  • 30. Bronchodilator safety in chronic obstructive pulmonary disease-reply.
    Stanbrook MB; Campitelli M; Gershon A
    JAMA Intern Med; 2014 Apr; 174(4):648. PubMed ID: 24711200
    [No Abstract]   [Full Text] [Related]  

  • 31. Bronchodilator safety in chronic obstructive pulmonary disease: time to focus?
    van Dijk WD; Käyser SC
    JAMA Intern Med; 2014 Apr; 174(4):647. PubMed ID: 24711198
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD.
    Verhamme KM; Afonso A; Romio S; Stricker BC; Brusselle GG; Sturkenboom MC
    Eur Respir J; 2013 Sep; 42(3):606-15. PubMed ID: 23520322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tiotropium HandiHaler improves the survival of patients with COPD: a systematic review and meta-analysis.
    Mathioudakis AG; Kanavidis P; Chatzimavridou-Grigoriadou V; Gialmanidis IP; Amanetopoulou SG; Christopoulou E; Evangelopoulou E; Mathioudakis GA
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):43-50. PubMed ID: 23521168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD.
    Verhamme KM; Afonso AS; van Noord C; Haag MD; Koudstaal PJ; Brusselle GG; Sturkenboom MC
    Pulm Pharmacol Ther; 2012 Feb; 25(1):19-26. PubMed ID: 22051450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Not Available].
    Fischer S
    Med Monatsschr Pharm; 2014 Feb; 37(2):79-80. PubMed ID: 24624613
    [No Abstract]   [Full Text] [Related]  

  • 36. Outpatient management of severe COPD.
    Singh S; Loke YK; Furberg CD
    N Engl J Med; 2010 Jul; 363(5):493-4; author reply 494-5. PubMed ID: 20666630
    [No Abstract]   [Full Text] [Related]  

  • 37. Bronchodilator efficacy of tiotropium-formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD.
    Salvi S; Brashier B; Gothi D; Karkhanis V; Madas S; Gogtay J; Joshi J
    Pulm Pharmacol Ther; 2014 Feb; 27(1):90-5. PubMed ID: 23752057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials.
    Dong YH; Lin HH; Shau WY; Wu YC; Chang CH; Lai MS
    Thorax; 2013 Jan; 68(1):48-56. PubMed ID: 23042705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD.
    Maltais F; Mahler DA; Pepin V; Nadreau E; Crater GD; Morris AN; Emmett AH; Ferro TJ
    Eur Respir J; 2013 Aug; 42(2):539-41. PubMed ID: 23904549
    [No Abstract]   [Full Text] [Related]  

  • 40. The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.
    van Noord JA; Cornelissen PJ; Aumann JL; Platz J; Mueller A; Fogarty C
    Respir Med; 2009 Jan; 103(1):22-9. PubMed ID: 19022642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.